Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Graf

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Health Economics Review|August 4, 2016
Benefit assessment in Germany: implications for price discountsUlrike Theidel, J-Matthias Graf von der Schulenburg
Pharmazie in Unserer Zeit|August 7, 2002
[Demographic challenges and medical research. Pharmacoeconomic aspects of treatment of dementia patients]Werner Kulp, J Matthias Graf v d Schulenburg
Pharmacoeconomics|May 20, 2003
Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in GermanyChrista Claes, Johann-Matthias Graf von der Schulenburg
Physical Chemistry Chemical Physics : PCCP|November 1, 2017
Dealloying progress during nanoporous structure evolution analyzed by in situ resistometryEva-Maria Steyskal, Michael Seidl, Matthias Graf, et al.
Medical & Biological Engineering & Computing|April 23, 2014
Automatic string generation for estimating in vivo length changes of the medial patellofemoral ligament during knee flexionMatthias Graf, Salomon Diether, Lazaros Vlachopoulos, et al.
Pharmazie in Unserer Zeit|October 7, 2003
[Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists]Werner Kulp, Wolfgang Greiner, J Matthias Graf von der Schulenburg
Health Economics Review|March 27, 2021
Note from the editor, January 2021J-Matthias Graf von der Schulenburg, Sebastian Braun, Jan Zeidler
Nanoscale|November 9, 2017
Electrocatalytic methanol oxidation with nanoporous gold: microstructure and selectivityMatthias Graf, Mareike Haensch, Jörg Carstens, et al.
Pharmacoeconomics|February 21, 2018
German Value Set for the EQ-5D-5LKristina Ludwig, J-Matthias Graf von der Schulenburg, Wolfgang Greiner
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 6, 2016
Cost analysis of whole genome sequencing in German clinical practiceMarika Plöthner, Martin Frank, J-Matthias Graf von der Schulenburg
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Health Economics Review|August 4, 2016
Benefit assessment in Germany: implications for price discountsUlrike Theidel, J-Matthias Graf von der Schulenburg
Pharmazie in Unserer Zeit|August 7, 2002
[Demographic challenges and medical research. Pharmacoeconomic aspects of treatment of dementia patients]Werner Kulp, J Matthias Graf v d Schulenburg
Pharmacoeconomics|May 20, 2003
Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in GermanyChrista Claes, Johann-Matthias Graf von der Schulenburg
Physical Chemistry Chemical Physics : PCCP|November 1, 2017
Dealloying progress during nanoporous structure evolution analyzed by in situ resistometryEva-Maria Steyskal, Michael Seidl, Matthias Graf, et al.
Medical & Biological Engineering & Computing|April 23, 2014
Automatic string generation for estimating in vivo length changes of the medial patellofemoral ligament during knee flexionMatthias Graf, Salomon Diether, Lazaros Vlachopoulos, et al.
Pharmazie in Unserer Zeit|October 7, 2003
[Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists]Werner Kulp, Wolfgang Greiner, J Matthias Graf von der Schulenburg
Health Economics Review|March 27, 2021
Note from the editor, January 2021J-Matthias Graf von der Schulenburg, Sebastian Braun, Jan Zeidler
Nanoscale|November 9, 2017
Electrocatalytic methanol oxidation with nanoporous gold: microstructure and selectivityMatthias Graf, Mareike Haensch, Jörg Carstens, et al.
Pharmacoeconomics|February 21, 2018
German Value Set for the EQ-5D-5LKristina Ludwig, J-Matthias Graf von der Schulenburg, Wolfgang Greiner
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 6, 2016
Cost analysis of whole genome sequencing in German clinical practiceMarika Plöthner, Martin Frank, J-Matthias Graf von der Schulenburg
Pageof 11